Scottish maritime firm receives £2.2million equity injection to scale up oil analysis device

Fast growing Scottish based maritime technology company RAB-Microfluidics, is scaling up manufacturing of a disruptive new oil analysis device after receiving £2.2million in equity funding led by Par Equity.

RAB Microfluidics is led by CEO Rotimi Alabi, a PHD graduate from Nigeria. The company has developed and patented a microfluidic ‘lab on a chip’ after identifying a gap in the market to radically improve oil lubrication analysis. The technology diagnoses early signs of failure preventing costly machinery break downs in equipment like main engines, gearboxes, and generators. The  device will be formally launched later this year and enables real-time analysis at sea up to 1000 times quicker and significantly cheaper than static land-based laboratories.

To drive growth RAB-Microfluidics is already moving to bigger premises at Aberdeen’s Energy Development Centre to kickstart manufacturing as well as moving towards regulatory approvals for CE marking, ISO 9001, and marine type approval. It is further creating eight new roles with the funding led by Par Equity and supported by existing investors, Eos Advisory, Newable Ventures and Scottish Enterprise. It is the second equity cash injection the company has received from the partners after it secured £1.25million in January 2021.

Dr Alabi said the company is winning new business and is aiming to hit a £2million turnover by 2024. He said growth will be driven by a strengthened team of engineers, scientists, and sales professionals.

“This is a huge moment for RAB-Microfluidics as we look to launch the technology and we must sincerely thank our investors for backing us and believing in our vision,” he said. “The technology fills a big gap in the engine condition monitoring market. We’ll use the funding to catapult the business forward commercially with a stronger corporate, sales and marketing operation. We are actively looking to speak with ship owners worldwide and urge ship managers to make contact. To raise awareness, we’ll be showcasing the technology at trade fairs globally starting at SMM in Hamburg in September.”

Jamie Grant, RAB-Microfluidics director of commercialisation and former general manager with V Group, said a big benefit of the technology is maximising vessel reliability and availability.

“It is brilliant to receive this equity funding after proving the technology’s potential on pilot projects working with the likes of NorthLink Ferries,” he said. “We know a major pain point in shipping is equipment failure, which is costly in terms of revenue, downtime and repair costs. A ship out of service is a stranded asset not maximising revenue. We can solve that difficulty by preventing break downs ever happening with quicker, cheaper analysis. RAB-Microfluidics technology is deployable on ferries, cruise ships, superyachts, and tankers and integrates its data with existing asset management technologies to maximise efficiency.”

Following its launch in the maritime industry, RAB-Microfluidics is planning to expand into other sectors including windfarms, manufacturing and mining working on gas turbines, gearboxes, generators, compressors and pumps.

RAB Microfluidics will be exhibiting in the UK Pavilion at SMM.

Ivan Hunter Gordon, Investment Manager at Newable Ventures said:

“For Newable Ventures to have invested a second time into RAB Microfluidics is reflective of our belief in the company’s technology; in particular its ability to offer significant efficiency gains in the oil condition monitoring space, both from an economic and sustainability perspective. We have been impressed with the growth of the team and the product over the last 18 months and are excited to see what the next few years hold.”



RAB-Microfluidics is building a solid track record in industry after receiving funding from a variety of sources including the Clean Maritime Demonstration Competition, run by Innovate UK on behalf of the Department for Transport.

Dr Alabi was further awarded a £90,000 Enterprise Fellowship by the Royal Society of Edinburgh, building on £65,000 of grant funding from the Oil and Gas Innovation Centre and Energy Technology Partnership. RAB-Microfluidics has also completed the Oil and Gas Technology Centre’s TechX Pioneers accelerator programme. The company has further won the University Start-up World Cup in Copenhagen, defeating 70 other entrants. This is in addition to receiving 70% grant support form Scottish Enterprise and Innovate UK for projects worth £475,000 and £232,000 respectively to further advance its technology



Newable is the leading provider of Money, Advice and Workspace to SMEs. Newable has consistently generated inclusive social and economic impact since its foundation. Now employing over 850 staff, it has grown to become a national business with a presence from Aberdeen to Brighton, serving over 43,000 client companies each year.



Newable Ventures is an EIS evergreen Fund that invests in 7-10 portfolio companies in the SpaceTech, MedTech and Automation sectors.

Risk warning: Your capital is at risk. Investing in early-stage companies involves risks including loss of capital, illiquidity, lack of dividends and dilution. These investments may not be covered by the Financial Services Compensation Scheme. Newable Ventures Limited does not give tax or investment advice. The availability of tax relief depends on individual investors’ circumstances, and on investee companies’ qualifying status, both of which may be subject to change. If you are in doubt about eligibility for tax reliefs or the tax treatment of your investment, you should seek independent tax advice. Please read our risk statement here.

Newable Ventures Limited (FRN 843924) is authorised and regulated by the Financial Conduct Authority. Registered in England and Wales | Registered number 10303336 | VAT number 237 9198 23 | Registered office 140 Aldersgate Street, London, EC1A 4HY. Newable Ventures Limited is registered with the Information Commissioner’s Office (ICO) with the registered Data Protection Number ZA789052.